	Three-dimensional multimodal fractal dynamics integrating spatial metabolism, cytoarchitecture, and perfusion for preoperative prediction of microvascular invasion in colorectal liver metastases. J Transl Med Guo Z, Guo C, Lu Z, Zou K, Zhang H. PMID: 42919290 [PubMed - indexed for MEDLINE]
	The CONVERGENCE trial protocol: a phase II/III trial for conversion surgery for gastric cancer with peritoneal metastases. BMC Cancer Chia DK, Tan YC, Tai BC, Chan XY, Badgwell B, Bencivenga M, Boshier P, Brandl A, Chan S, Guiral DC, Duong C, Elliott JA, Eveno C, Kanonnikoff TF, Gisbertz SS, Haag GM, Hagiwara K, van Berge Henegouwen MI, De Hingh I, Kim HI, Long VD, Law S, Lee HJ, Luyer M, Markar S, Mariani A, de Manzoni G, Ong CJ, Rau B, Koehler F, Guel-Klein S, Rha SY, Van Sandick J, Sgabura O, Shabbir A, Takahashi AML, Vollebergh M, Wijnhoven B, Woo Y, Wong IY, Yamashita H, Glehen O, Nilsson M, Yong WP, So JB. PMID: 42919242 [PubMed - indexed for MEDLINE]
	Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study. BMC Cancer Iida M, Nakashima C, Kawaoka T, Kondo J, Yamamoto T, Yoshino S, Tokuno K, Kuga T, Dairaku K, Nakagami Y, Watanabe Y, Matsui H, Shindo Y, Takahashi H, Ioka T, Nagano H. PMID: 42919216 [PubMed - indexed for MEDLINE]
	Seroprevalence of Toxoplasma gondii infection, associated risk factors, and circulating IL-6 and VEGF-A levels in colorectal cancer patients: a case-control study from western Iran. BMC Infect Dis Moayyedkazemi A, Hematpour M, Khudair Khalaf A, Ahmadi Somaghian S, Sepahvand M, Baharvand P, Mahmoudvand H. PMID: 42919200 [PubMed - indexed for MEDLINE]
	meth-SemiCancer2: a cancer subtyping framework leveraging domain adaptation with contrastive learning for batch effect correction in DNA methylation profiles. BMC Bioinformatics Choi JM, Chae H. PMID: 42919130 [PubMed - in process]
	Early-Onset Colorectal Cancer: Epidemiology, Etiologic Pathways, and Emerging Prevention Strategies. Clin Colorectal Cancer Syal A, Cohen SJ. PMID: 42918681 [PubMed - as supplied by publisher]
	Active surveillance versus standard surgery after neoadjuvant chemoradiotherapy for oesophageal cancer: long-term results of a cluster-randomised controlled trial (SANO). Ann Oncol Panday SSGG, van der Wilk BJ, Lagarde SM, Eyck BM, Rosman C, Noordman BJ, Valkema MJ, Bisseling TM, Coene PPLO, van Det MJ, Dekker JWT, van Dieren JM, Doukas M, van Esser S, Fiets WE, Hartgrink HH, Heisterkamp J, Holster IL, Klarenbeek B, Kouw E, Kouwenhoven EA, Luyer MD, Mostert B, Nieuwenhuijzen GAP, Oostenbrug LE, Pierie JP, van Sandick JW, Sosef MN, Spaander MCW, Valkema R, van der Zaag ES, Steyerberg EW, van Klaveren D, Wijnhoven BPL, van Lanschot JJB, SANO Study Group. PMID: 42918421 [PubMed - as supplied by publisher]
	Trends and Facility-Level Variation in Minimally Invasive and Sphincter-Preserving Rectal Cancer Surgery in Veterans Health Administration: A Retrospective Cohort Study. J Gastrointest Surg Kwan KL, Yuan AH, Jackson NJ, Saliba D, Washington DL, Russell MM. PMID: 42918398 [PubMed - as supplied by publisher]
	Machine Learning-Assisted, Ago-Mediated Droplet Fluorescence Analysis with a Knowledge-Enabled Agent for Colorectal Cancer Diagnostics. Anal Chem Li H, Wu K, Tang C, Li H, Li L, Kong J, Chen H. PMID: 42915305 [PubMed - indexed for MEDLINE]
	Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-Intestinal Trials Group. Lancet Oncol Oar A, Kneebone A, Sjoquist KM, Espinoza D, Lee M, Le H, Gholamrezaei L, Chu J, Lynam J, Mallesara G, Lee D, Vignarajah D, Ward I, Samra J, Barbour A, Whitehead A, Brooks S, Nicholson A, Wang TW, Ng W, Ali F, Siu D, Gaitan JL, Cook O, Moore A, Oostendorp MB, Yip S, Shakeshaft J, Pryor D, Nguyen N, Goldstein D, Australasian Gastro-Intestinal Trials Group (AGITG). PMID: 42914998 [PubMed - as supplied by publisher]
	Prognostic Modeling Integrating RAS and SMAD4 Status in Patients with BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer. Cancer Res Commun Nasca V, Tinè G, Walch H, Maddalena G, Germani MM, Ghelardi F, Perissinotto E, Boccaccio C, Manca P, Fassan M, Landi M, Damonte C, Gusmaroli E, Garavaglia A, Bergamo F, Cremolini C, Lonardi S, Miceli R, Pietrantonio F, Randon G. PMID: 42914957 [PubMed - as supplied by publisher]
	"A new normal": A qualitative study of emotional and psychosocial concerns in early-onset colorectal cancer survivors. Am J Surg Kravchenko T, Vitous CA, Bradley SE, Marzoughi M, Ashmead-Meers C, Jacobson CE, Norton TE, Boyce-Suwanabol J, Wallner LP, Suwanabol PA. PMID: 42914939 [PubMed - as supplied by publisher]
	Benzodiazepine-based N,S-heterocyclic hybrids as multi-target therapeutic candidates for cancer and inflammation: enzymatic evaluation, cellular mechanistic studies, in vivo anti-inflammatory assessment, and computational investigations. Bioorg Chem El-Hema HS, Abed MA, Hawata MA, Nossier ES, Salama A, Hussein MF, Elhendawy AT, El-Sayed HA, Abdel-Rahman AA. PMID: 42914874 [PubMed - as supplied by publisher]
	Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL). Gynecol Oncol Coquan E, Vion R, Colomba-Blamemble E, Frenel JS, Abdeddaim C, D'Hondt V, Abadie-Lacourtoisie S, Dubot C, Brachet PE, Castera M, Leconte A, Beaussire-Trouvay L, Clatot F, Joly F, Lequesne J, Clarisse B. PMID: 42914775 [PubMed - as supplied by publisher]
	Drivers of Change in Radiotherapy Practice: Lessons From a UK Tertiary Cancer Centre (2013-2023). Clin Oncol (R Coll Radiol) Kapadi A, Price G, Faivre-Finn C, Holley R, Banfill K, Walls G, Marchant T, Radhakrishna G, Price J, Choudhury A, Anandadas C, Borst G, Whitfield GA, French DP. PMID: 42914601 [PubMed - as supplied by publisher]
	Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Radiother Oncol Liermann J, Naumann P, Jäkel C, Baumann L, Koczur B, Röhrich M, Englert FH, Jessen I, Tawk B, Knoll M, Baltazar F, Harrabi S, Springfeld C, Michalski C, Haberkorn U, Mairani A, Abdollahi A, Kieser M, Debus J, Herfarth K. PMID: 42913944 [PubMed - as supplied by publisher]
	Organ Preservation With Total Neoadjuvant Therapy (OPTNT) for Early Low Rectal Cancer: Short-Term Outcomes of a Nonrandomized Phase 2 Clinical Trial. Int J Radiat Oncol Biol Phys Xian Z, Feng Q, Qian Y, Wei Y, Ren L, Ye L, Zhong Y, Chang W, Rao S, Liu L, Huang L, Ji Y, Wang Y, Xu JM, Wang J. PMID: 42913867 [PubMed - as supplied by publisher]
	Survival rates and associated risk factors in colorectal cancer treatment. Cir Cir Atalay S, Cemel H, Surmelíoglu A. PMID: 42913518 [PubMed - indexed for MEDLINE]
	Analysing the implementation and transferability of an enhanced care pathway integrating systematic supportive cancer care and patient-partner support for people living with anal cancer: Protocol for a mixed-methods study in two French cancer centres. PLoS One Carillon S, Faure R, Del Rio M, Lemanski C, Tyran M, de Montgolfier S, SOS . PMID: 42912772 [PubMed - indexed for MEDLINE]
	Trends in Direct Oral Anticoagulant Use for Cancer-Associated Venous Thromboembolism. JAMA Netw Open Varnier R, Bettega F, Moskal A, Mainbourg S, Wespiser M, Rousseau A, Viprey M. PMID: 42912389 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 246420

Page 1 of 12321



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy